Supply Anti-Gout Febuxostat Powder CAS 144060-53-7
Description of raw materials:
Febuxostat is a new generation xanthine oxidase inhibitor developed by Tejin Co. (Japan,) used clinically for for long-term treatment of hyperuicemia (gout,) a new and highly effective non-purine selective inhibitor of xanthine oxidase. It is not recommended for gout patients without hyperuricemia.
Product Description:
| Product Name: | Febuxostat |
| Synonyms: | Febuxostat (Uloric);FBX;Uloric;Febuxostat (TEI-6720);Febuxostat Tablets;FEBUXOSTAT API;Febuxostat (This product is unavailable in the U.S.);Febuxostat Tabletshehe |
| CAS: | 144060-53-7 |
| MF: | C16H16N2O3S |
| MW: | 316.37 |
| EINECS: | 682-158-6 |
| Product Categories: | Heterocycles;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;TRILIPIX;eterocycles;zjh;API;Febuxostat;Other APIs |
